Osteoarthritis (OA) is one of the most frequent degenerative joint diseases characterized by joint pain and stiffness traditionally treated with symptomatic drugs such as oral nonsteroidal anti-inflammatory drugs (NSAIDs )and, in extreme cases, with intra-articular corticoids. However, both these drugs are not exempt from adverse effects. Curcumin (Cur) has proven its anti-inflammatory properties and its potential as an anti-osteoarthritic drug. However, its low solubility hinders its usage and limits its therapeutic efficacy. To overcome this issue, drug-in-cyclodextrin–double-loaded liposomes (DCL–DL) were developed. These liposomes contained free drug in the lipid bilayer and drug–cyclodextrin complex in the aqueous compartment. The aim of this work was to evaluate the actual effectiveness of Cur–DCL–DL formulations in the OA treatment by intra-articular treatment. For this purpose, the monoiodoacetate (MIA) model of OA pain in rats was used. A single dose of samples containing Cur as DCL–DL, conventional liposomes (SL), and empty liposomes (EL, as control) were injected once intra-articularly. Paw pressure, beam balance, and incapacitation tests were performed to evaluate OA progression at 7 and 14 days. After ending the assay, animals were sacrificed, and histological evaluation of the ankle-joint tissue was performed. Results showed that DCL–DL significantly reduced pain and ameliorated the balance and gait of rats over the 14 days, compared to SL. Histological tests showed that DCL–DL had protective properties in some aspects of OA. Keywords: drug-in-cyclodextrin-in-liposomes; double-loaded liposomes; curcumin; osteoarthritis 1. Introduction Osteoarthritis (OA) is an inflammatory joint disease that affects primarily the elderly. This disease is characterized by progressive degradation of articular cartilage, synovial hyperplasia, osteophyte formation, and subchondral bone injury [1]. Currently, OA pharmacotherapy is oriented toward pain relief and improving function by means of NSAIDs, cyclooxygenase (COX)-inhibitors, weak opioids administrated orally, or hyaluronic acid and glucocorticoids administrated via intra-articular injection [2]. However, except for hyaluronic acid, these drugs have numerous adverse effects. To solve this issue, many researchers propose the use of natural products, such as curcumin.

Curcumin-in-Cyclodextrins-in-Liposomes: An Alternative for Osteoarthritis Treatment / Maestrelli, Francesca; González-Rodríguez, María Luisa; Fernández-Romero, Ana-María; Mura, Paola Angela; Rabasco, Antonio M.; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla. - In: PROCEEDINGS. - ISSN 2504-3900. - ELETTRONICO. - 78:(2020), pp. 0-0. [10.3390/IECP2020-08720]

Curcumin-in-Cyclodextrins-in-Liposomes: An Alternative for Osteoarthritis Treatment

Maestrelli, Francesca
Writing – Review & Editing
;
Mura, Paola Angela
Supervision
;
Micheli, Laura
Formal Analysis
;
Mannelli, Lorenzo Di Cesare
Validation
;
Ghelardini, Carla
Supervision
2020

Abstract

Osteoarthritis (OA) is one of the most frequent degenerative joint diseases characterized by joint pain and stiffness traditionally treated with symptomatic drugs such as oral nonsteroidal anti-inflammatory drugs (NSAIDs )and, in extreme cases, with intra-articular corticoids. However, both these drugs are not exempt from adverse effects. Curcumin (Cur) has proven its anti-inflammatory properties and its potential as an anti-osteoarthritic drug. However, its low solubility hinders its usage and limits its therapeutic efficacy. To overcome this issue, drug-in-cyclodextrin–double-loaded liposomes (DCL–DL) were developed. These liposomes contained free drug in the lipid bilayer and drug–cyclodextrin complex in the aqueous compartment. The aim of this work was to evaluate the actual effectiveness of Cur–DCL–DL formulations in the OA treatment by intra-articular treatment. For this purpose, the monoiodoacetate (MIA) model of OA pain in rats was used. A single dose of samples containing Cur as DCL–DL, conventional liposomes (SL), and empty liposomes (EL, as control) were injected once intra-articularly. Paw pressure, beam balance, and incapacitation tests were performed to evaluate OA progression at 7 and 14 days. After ending the assay, animals were sacrificed, and histological evaluation of the ankle-joint tissue was performed. Results showed that DCL–DL significantly reduced pain and ameliorated the balance and gait of rats over the 14 days, compared to SL. Histological tests showed that DCL–DL had protective properties in some aspects of OA. Keywords: drug-in-cyclodextrin-in-liposomes; double-loaded liposomes; curcumin; osteoarthritis 1. Introduction Osteoarthritis (OA) is an inflammatory joint disease that affects primarily the elderly. This disease is characterized by progressive degradation of articular cartilage, synovial hyperplasia, osteophyte formation, and subchondral bone injury [1]. Currently, OA pharmacotherapy is oriented toward pain relief and improving function by means of NSAIDs, cyclooxygenase (COX)-inhibitors, weak opioids administrated orally, or hyaluronic acid and glucocorticoids administrated via intra-articular injection [2]. However, except for hyaluronic acid, these drugs have numerous adverse effects. To solve this issue, many researchers propose the use of natural products, such as curcumin.
2020
78
0
0
Maestrelli, Francesca; González-Rodríguez, María Luisa; Fernández-Romero, Ana-María; Mura, Paola Angela; Rabasco, Antonio M.; Micheli, Laura; Mannelli...espandi
File in questo prodotto:
File Dimensione Formato  
proceedings-78-00052 (3).pdf

accesso aperto

Descrizione: articolo
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 276.96 kB
Formato Adobe PDF
276.96 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1277701
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact